Prologis (PLD)
NYSE: PLD · REIT—Industrial · San Francisco, CA
Our rating: Neutral
Neutral reaffirmed at $128.02, moderate conviction, October 29, 2026.
Breaks if: The Neutral call turns Cautious if Prologis reports FFO below $5.5 billion on a trailing twelve-month basis — an 8% or greater decline from the current approximate $6.0 billion — within the next four quarterly periods, or if the stock advances above $156 within the next twelve months without concurrent improvement in reported AFFO coverage or same-store NOI growth that would justify roughly 24× FFO. It turns Positive if the price falls to approximately $100 or below — around 16× current FFO — without a corresponding deterioration in occupancy or FFO per share, or if the next two quarterly disclosures confirm AFFO dividend coverage above 120% alongside same-store NOI growth of 5% or more.
Key figures
| Market value | $114.2B |
|---|---|
| Revenue, last 12 months | $8.9B |
| Net income, last 12 months | $3.7B |
| Free cash flow, last 12 months | n/a |
| Price to earnings | 30.7× |
| Free cash flow yield | n/a |
| Dividend yield | 3.4% |
| Operating margin | 52.4% |
| Return on equity | 7.0% |
| Beta to the S&P 500 | 0.71 |
| Volatility, annualized | 24.9% |
Reported quarters
| Quarter ending | Revenue | Year on year | Earnings per share | Free cash flow |
|---|---|---|---|---|
| March 31, 2026 | $2.3B | 7.4% | $1.05 | n/a |
| December 31, 2025 | $2.3B | 2.4% | $1.49 | n/a |
| September 30, 2025 | $2.2B | 8.7% | $0.82 | n/a |
| June 30, 2025 | $2.2B | 8.8% | $0.61 | n/a |
| March 31, 2025 | $2.1B | 9.4% | $0.63 | n/a |
| December 31, 2024 | $2.2B | 16.5% | $1.37 | n/a |
| September 30, 2024 | $2.0B | 6.4% | $1.08 | n/a |
| June 30, 2024 | $2.0B | −18.1% | $0.92 | n/a |
13 ledger entries and 37 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.